

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.71116304 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.71116304 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 5.71116304 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.71116304 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.71116304 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.71116304 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.42405742 |
| 8 | positive regulation of interferon-alpha production (GO:0032727) | 4.95928124 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.77598518 |
| 10 | immunoglobulin mediated immune response (GO:0016064) | 4.68654053 |
| 11 | regulation of interferon-alpha production (GO:0032647) | 4.65660295 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.52002884 |
| 13 | response to peptidoglycan (GO:0032494) | 4.51719939 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.50869250 |
| 15 | NIK/NF-kappaB signaling (GO:0038061) | 4.47574777 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 4.46326436 |
| 17 | response to muramyl dipeptide (GO:0032495) | 4.45904644 |
| 18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.41507376 |
| 19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.41507376 |
| 20 | cellular response to type I interferon (GO:0071357) | 4.28115122 |
| 21 | type I interferon signaling pathway (GO:0060337) | 4.28115122 |
| 22 | positive regulation of antigen processing and presentation (GO:0002579) | 4.26952074 |
| 23 | response to type I interferon (GO:0034340) | 4.24035399 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.22256854 |
| 25 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.07681328 |
| 26 | response to host immune response (GO:0052572) | 3.98480024 |
| 27 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.98480024 |
| 28 | response to interferon-alpha (GO:0035455) | 3.91221187 |
| 29 | regulation of skeletal muscle contraction (GO:0014819) | 3.84656474 |
| 30 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.81335345 |
| 31 | positive regulation of interferon-beta production (GO:0032728) | 3.75854820 |
| 32 | regulation of RIG-I signaling pathway (GO:0039535) | 3.74473512 |
| 33 | regulation of antigen processing and presentation (GO:0002577) | 3.73255704 |
| 34 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.70684365 |
| 35 | natural killer cell mediated immunity (GO:0002228) | 3.67737543 |
| 36 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.67737543 |
| 37 | positive regulation of B cell differentiation (GO:0045579) | 3.67354703 |
| 38 | response to host (GO:0075136) | 3.67191651 |
| 39 | response to host defenses (GO:0052200) | 3.67191651 |
| 40 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.67191651 |
| 41 | cellular response to interferon-beta (GO:0035458) | 3.66109555 |
| 42 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.62733607 |
| 43 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.61944206 |
| 44 | granulocyte activation (GO:0036230) | 3.59226775 |
| 45 | neutrophil activation (GO:0042119) | 3.58738496 |
| 46 | microglial cell activation (GO:0001774) | 3.51511489 |
| 47 | defense response to protozoan (GO:0042832) | 3.51447872 |
| 48 | respiratory burst (GO:0045730) | 3.50520532 |
| 49 | myeloid cell activation involved in immune response (GO:0002275) | 3.47894091 |
| 50 | negative regulation of viral genome replication (GO:0045071) | 3.46097223 |
| 51 | B cell mediated immunity (GO:0019724) | 3.45466378 |
| 52 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.36009461 |
| 53 | response to interferon-beta (GO:0035456) | 3.34608782 |
| 54 | skeletal muscle contraction (GO:0003009) | 3.33234917 |
| 55 | myeloid dendritic cell activation (GO:0001773) | 3.31643521 |
| 56 | muscle filament sliding (GO:0030049) | 3.31159740 |
| 57 | actin-myosin filament sliding (GO:0033275) | 3.31159740 |
| 58 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.29647306 |
| 59 | myeloid dendritic cell differentiation (GO:0043011) | 3.27198246 |
| 60 | negative regulation of cell killing (GO:0031342) | 3.26456703 |
| 61 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.26456703 |
| 62 | cellular response to virus (GO:0098586) | 3.21794564 |
| 63 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.20551276 |
| 64 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.17051892 |
| 65 | positive regulation of interleukin-12 production (GO:0032735) | 3.16443997 |
| 66 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.13567029 |
| 67 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.12458601 |
| 68 | cellular response to exogenous dsRNA (GO:0071360) | 3.12116754 |
| 69 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.11341561 |
| 70 | negative regulation of granulocyte differentiation (GO:0030853) | 3.10710591 |
| 71 | response to protozoan (GO:0001562) | 3.06807447 |
| 72 | macrophage activation (GO:0042116) | 3.05950837 |
| 73 | regulation of B cell differentiation (GO:0045577) | 3.04755261 |
| 74 | detection of molecule of bacterial origin (GO:0032490) | 3.04654929 |
| 75 | dendritic cell differentiation (GO:0097028) | 3.03636986 |
| 76 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.03269452 |
| 77 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.98374231 |
| 78 | germinal center formation (GO:0002467) | 2.98259672 |
| 79 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.98259659 |
| 80 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.95890701 |
| 81 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.95359048 |
| 82 | I-kappaB phosphorylation (GO:0007252) | 2.93933847 |
| 83 | negative regulation of interleukin-12 production (GO:0032695) | 2.93187850 |
| 84 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.92098329 |
| 85 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.91748887 |
| 86 | neuronal action potential propagation (GO:0019227) | 2.90182591 |
| 87 | creatine metabolic process (GO:0006600) | 2.88768160 |
| 88 | negative regulation of interleukin-17 production (GO:0032700) | 2.88704789 |
| 89 | regulation of gamma-delta T cell activation (GO:0046643) | 2.86648471 |
| 90 | myeloid leukocyte activation (GO:0002274) | 2.84916772 |
| 91 | mature B cell differentiation (GO:0002335) | 2.83025110 |
| 92 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.83007886 |
| 93 | regulation of interferon-beta production (GO:0032648) | 2.82381811 |
| 94 | T cell migration (GO:0072678) | 2.81884533 |
| 95 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.81824977 |
| 96 | regulation of necroptotic process (GO:0060544) | 2.80869243 |
| 97 | regulation of mast cell degranulation (GO:0043304) | 2.80346966 |
| 98 | regulation of interleukin-12 production (GO:0032655) | 2.79339624 |
| 99 | neutrophil mediated immunity (GO:0002446) | 2.78738615 |
| 100 | leukocyte mediated cytotoxicity (GO:0001909) | 2.77308204 |
| 101 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.76983264 |
| 102 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.76364404 |
| 103 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.74663415 |
| 104 | cellular response to interferon-gamma (GO:0071346) | 2.74632430 |
| 105 | positive regulation of response to biotic stimulus (GO:0002833) | 2.74222566 |
| 106 | positive regulation of heat generation (GO:0031652) | 2.74109202 |
| 107 | defense response to virus (GO:0051607) | 2.74016913 |
| 108 | activated T cell proliferation (GO:0050798) | 2.73706043 |
| 109 | superoxide anion generation (GO:0042554) | 2.70800649 |
| 110 | lymphocyte mediated immunity (GO:0002449) | 2.69325741 |
| 111 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.68044322 |
| 112 | cellular response to zinc ion (GO:0071294) | 2.66543719 |
| 113 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.64195517 |
| 114 | postsynaptic membrane organization (GO:0001941) | 2.60850485 |
| 115 | membrane depolarization during action potential (GO:0086010) | 2.59693648 |
| 116 | response to inactivity (GO:0014854) | 2.59656271 |
| 117 | skeletal muscle adaptation (GO:0043501) | 2.56695443 |
| 118 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.54627559 |
| 119 | actin-mediated cell contraction (GO:0070252) | 2.54565410 |
| 120 | regulation of relaxation of muscle (GO:1901077) | 2.51796780 |
| 121 | neuromuscular synaptic transmission (GO:0007274) | 2.49873560 |
| 122 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.47894742 |
| 123 | striated muscle contraction (GO:0006941) | 2.42248072 |
| 124 | negative regulation of protein oligomerization (GO:0032460) | 2.40175355 |
| 125 | behavioral response to nicotine (GO:0035095) | 2.40144086 |
| 126 | regulation of synapse structural plasticity (GO:0051823) | 2.39987917 |
| 127 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.39081589 |
| 128 | dendritic spine morphogenesis (GO:0060997) | 2.37184967 |
| 129 | myofibril assembly (GO:0030239) | 2.36511942 |
| 130 | positive regulation of Rap GTPase activity (GO:0032854) | 2.32615595 |
| 131 | skeletal muscle fiber development (GO:0048741) | 2.20709644 |
| 132 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.20383419 |
| 133 | synaptic transmission, cholinergic (GO:0007271) | 2.19730340 |
| 134 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.18854374 |
| 135 | regulation of synapse maturation (GO:0090128) | 2.14359986 |
| 136 | positive thymic T cell selection (GO:0045059) | 2.13514126 |
| 137 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.12327617 |
| 138 | mannose metabolic process (GO:0006013) | 2.12273311 |
| 139 | positive regulation of synapse maturation (GO:0090129) | 2.10199594 |
| 140 | positive regulation of mast cell activation (GO:0033005) | 2.09946678 |
| 141 | actin filament-based movement (GO:0030048) | 2.09101483 |
| 142 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.07263034 |
| 143 | synaptic vesicle maturation (GO:0016188) | 2.04026696 |
| 144 | macroautophagy (GO:0016236) | 2.03524407 |
| 145 | striated muscle atrophy (GO:0014891) | 2.03232537 |
| 146 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.03060723 |
| 147 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.02776406 |
| 148 | negative regulation of T cell mediated immunity (GO:0002710) | 2.02709329 |
| 149 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.02189286 |
| 150 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.00694618 |
| 151 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.00648264 |
| 152 | regulation of Rap GTPase activity (GO:0032317) | 1.99956149 |
| 153 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 1.99310615 |
| 154 | positive T cell selection (GO:0043368) | 1.97744495 |
| 155 | interferon-gamma production (GO:0032609) | 1.96657072 |
| 156 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 1.95975809 |
| 157 | positive regulation of mast cell degranulation (GO:0043306) | 1.95975809 |
| 158 | negative thymic T cell selection (GO:0045060) | 1.95170145 |
| 159 | myotube cell development (GO:0014904) | 1.94809082 |
| 160 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 1.93627273 |
| 161 | regulation of ARF protein signal transduction (GO:0032012) | 1.93505216 |
| 162 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 1.93420980 |
| 163 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 1.92832707 |
| 164 | auditory behavior (GO:0031223) | 1.90704085 |
| 165 | nitric oxide mediated signal transduction (GO:0007263) | 1.89987531 |
| 166 | synaptic transmission, glutamatergic (GO:0035249) | 1.87011584 |
| 167 | cerebellar Purkinje cell differentiation (GO:0021702) | 1.86815405 |
| 168 | nucleobase catabolic process (GO:0046113) | 1.86136356 |
| 169 | muscle contraction (GO:0006936) | 1.84812994 |
| 170 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 1.84631307 |
| 171 | negative T cell selection (GO:0043383) | 1.84211812 |
| 172 | striated muscle adaptation (GO:0014888) | 1.84108072 |
| 173 | neurotransmitter-gated ion channel clustering (GO:0072578) | 1.83623941 |
| 174 | regulation of mast cell activation (GO:0033003) | 1.82245120 |
| 175 | synaptic vesicle exocytosis (GO:0016079) | 1.82056856 |
| 176 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 1.81871380 |
| 177 | calcium ion import (GO:0070509) | 1.81158087 |
| 178 | vocalization behavior (GO:0071625) | 1.81144380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.82244484 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.50873490 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.44016328 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.13672481 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.60402417 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.39497209 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.08812214 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.86591280 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.59235786 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.53849624 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.43710821 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.11545223 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.99462478 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.90782947 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.88218048 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.74906289 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.70330971 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.64980490 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.50864471 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.50857403 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.49694567 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.40741356 |
| 23 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.35849323 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.11682527 |
| 25 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.09861165 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08752391 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.03258109 |
| 28 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.00981657 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.00878331 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.96931213 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 1.96024162 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.93040654 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89914556 |
| 34 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.87493925 |
| 35 | MYB_26560356_Chip-Seq_TH2_Human | 1.85561929 |
| 36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.84268881 |
| 37 | * MAF_26560356_Chip-Seq_TH1_Human | 1.79360104 |
| 38 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76042027 |
| 39 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.76037783 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74587239 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.73078846 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.72598352 |
| 43 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.70468189 |
| 44 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.70132624 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.67698226 |
| 46 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.67559438 |
| 47 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.66586469 |
| 48 | MYB_26560356_Chip-Seq_TH1_Human | 1.64752376 |
| 49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.64421789 |
| 50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.62943012 |
| 51 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.62881926 |
| 52 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.61504239 |
| 53 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.60663462 |
| 54 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.59660612 |
| 55 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.55520347 |
| 56 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.48287517 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46620792 |
| 58 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45584783 |
| 59 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.45209708 |
| 60 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.43999154 |
| 61 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41069996 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40632297 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39108219 |
| 64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.38641849 |
| 65 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.38384939 |
| 66 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.38357458 |
| 67 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37433964 |
| 68 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.37406210 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36706170 |
| 70 | UTX_26944678_Chip-Seq_JUKART_Human | 1.35602883 |
| 71 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.35305713 |
| 72 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.34933272 |
| 73 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34184581 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33559991 |
| 75 | MYC_22102868_ChIP-Seq_BL_Human | 1.31113263 |
| 76 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.30313509 |
| 77 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.29341027 |
| 78 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28639143 |
| 79 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.28444732 |
| 80 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27932094 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26949688 |
| 82 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.23846365 |
| 83 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23780391 |
| 84 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.22135611 |
| 85 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.21469586 |
| 86 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.21469586 |
| 87 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.19311802 |
| 88 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.17848383 |
| 89 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17158566 |
| 90 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15914674 |
| 91 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15516006 |
| 92 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15506398 |
| 93 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.15291757 |
| 94 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15122117 |
| 95 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14041592 |
| 96 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.13996288 |
| 97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12799657 |
| 98 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11639819 |
| 99 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11115056 |
| 100 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.10170080 |
| 101 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08849044 |
| 102 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.08132925 |
| 103 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07379507 |
| 104 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06587380 |
| 105 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06308662 |
| 106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06255609 |
| 107 | MAF_26560356_Chip-Seq_TH2_Human | 1.03234369 |
| 108 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02550214 |
| 109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00682247 |
| 110 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00677653 |
| 111 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.00522944 |
| 112 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.99847576 |
| 113 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98349850 |
| 114 | KDM2B_26808549_Chip-Seq_K562_Human | 0.98145529 |
| 115 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.96883499 |
| 116 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.96701561 |
| 117 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96289110 |
| 118 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96233672 |
| 119 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95916331 |
| 120 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.95303728 |
| 121 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93395954 |
| 122 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92040714 |
| 123 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.91416430 |
| 124 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.89254051 |
| 125 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89178555 |
| 126 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88093036 |
| 127 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.87710034 |
| 128 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.86909085 |
| 129 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86160804 |
| 130 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.85746404 |
| 131 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85428406 |
| 132 | P68_20966046_ChIP-Seq_HELA_Human | 0.84900609 |
| 133 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.84735400 |
| 134 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84477735 |
| 135 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.84182560 |
| 136 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.83799841 |
| 137 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.81481000 |
| 138 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.81300344 |
| 139 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.78345142 |
| 140 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78291920 |
| 141 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.77769074 |
| 142 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77722037 |
| 143 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.77365955 |
| 144 | SA1_27219007_Chip-Seq_Bcells_Human | 0.77082581 |
| 145 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.76922391 |
| 146 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.76250627 |
| 147 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.76040393 |
| 148 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.74883174 |
| 149 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.74583507 |
| 150 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.74262831 |
| 151 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.73637796 |
| 152 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.72932417 |
| 153 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.72846466 |
| 154 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.72200495 |
| 155 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.71814163 |
| 156 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68255551 |
| 157 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.68143906 |
| 158 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.63669647 |
| 159 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.63412404 |
| 160 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.59149838 |
| 161 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.58868886 |
| 162 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.58705657 |
| 163 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57957903 |
| 164 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.57070196 |
| 165 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.57070196 |
| 166 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.57040927 |
| 167 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.56112658 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.66192670 |
| 2 | MP0004145_abnormal_muscle_electrophysio | 3.42076702 |
| 3 | MP0009785_altered_susceptibility_to | 3.40351900 |
| 4 | MP0003436_decreased_susceptibility_to | 3.17746637 |
| 5 | MP0000685_abnormal_immune_system | 3.09473282 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.01268080 |
| 7 | MP0004510_myositis | 2.98017615 |
| 8 | * MP0002419_abnormal_innate_immunity | 2.92040236 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.80769054 |
| 10 | MP0001790_abnormal_immune_system | 2.78564091 |
| 11 | MP0005387_immune_system_phenotype | 2.78564091 |
| 12 | MP0000569_abnormal_digit_pigmentation | 2.78431756 |
| 13 | * MP0005025_abnormal_response_to | 2.76196947 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.72349430 |
| 15 | * MP0002452_abnormal_antigen_presenting | 2.66886678 |
| 16 | MP0001800_abnormal_humoral_immune | 2.62757518 |
| 17 | MP0005671_abnormal_response_to | 2.57451549 |
| 18 | MP0002723_abnormal_immune_serum | 2.51777926 |
| 19 | MP0003303_peritoneal_inflammation | 2.45117543 |
| 20 | MP0006082_CNS_inflammation | 2.40304670 |
| 21 | MP0004130_abnormal_muscle_cell | 2.35866888 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.31083086 |
| 23 | * MP0001819_abnormal_immune_cell | 2.28810155 |
| 24 | MP0003724_increased_susceptibility_to | 2.27950280 |
| 25 | MP0004859_abnormal_synaptic_plasticity | 2.27797068 |
| 26 | * MP0002420_abnormal_adaptive_immunity | 2.24843142 |
| 27 | MP0004270_analgesia | 2.19065672 |
| 28 | MP0005464_abnormal_platelet_physiology | 2.14239580 |
| 29 | MP0000751_myopathy | 2.09261418 |
| 30 | MP0001853_heart_inflammation | 2.00185228 |
| 31 | MP0002396_abnormal_hematopoietic_system | 1.96914827 |
| 32 | MP0005174_abnormal_tail_pigmentation | 1.95937369 |
| 33 | MP0002405_respiratory_system_inflammati | 1.91904872 |
| 34 | MP0009278_abnormal_bone_marrow | 1.90615062 |
| 35 | MP0002822_catalepsy | 1.89666347 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.86896838 |
| 37 | MP0002006_tumorigenesis | 1.86715368 |
| 38 | MP0005423_abnormal_somatic_nervous | 1.85273398 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.81832272 |
| 40 | MP0002398_abnormal_bone_marrow | 1.80972285 |
| 41 | MP0000716_abnormal_immune_system | 1.76573354 |
| 42 | MP0000749_muscle_degeneration | 1.76551682 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.75289012 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.73095359 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.73095359 |
| 46 | MP0003635_abnormal_synaptic_transmissio | 1.72822340 |
| 47 | MP0000015_abnormal_ear_pigmentation | 1.71836595 |
| 48 | MP0004947_skin_inflammation | 1.70375655 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.66630103 |
| 50 | MP0002064_seizures | 1.66413623 |
| 51 | MP0002332_abnormal_exercise_endurance | 1.65706782 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.63916584 |
| 53 | MP0002106_abnormal_muscle_physiology | 1.60293254 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.59178212 |
| 55 | MP0003879_abnormal_hair_cell | 1.58430163 |
| 56 | MP0001501_abnormal_sleep_pattern | 1.58057736 |
| 57 | MP0003448_altered_tumor_morphology | 1.55702935 |
| 58 | MP0004036_abnormal_muscle_relaxation | 1.55227535 |
| 59 | MP0009764_decreased_sensitivity_to | 1.54155220 |
| 60 | MP0000343_altered_response_to | 1.53312422 |
| 61 | MP0004808_abnormal_hematopoietic_stem | 1.52204083 |
| 62 | MP0002063_abnormal_learning/memory/cond | 1.49769188 |
| 63 | MP0009745_abnormal_behavioral_response | 1.47718939 |
| 64 | MP0008469_abnormal_protein_level | 1.47645858 |
| 65 | MP0002429_abnormal_blood_cell | 1.47435300 |
| 66 | MP0005645_abnormal_hypothalamus_physiol | 1.46791107 |
| 67 | MP0002837_dystrophic_cardiac_calcinosis | 1.43548702 |
| 68 | MP0001970_abnormal_pain_threshold | 1.41589301 |
| 69 | MP0002722_abnormal_immune_system | 1.40491501 |
| 70 | MP0002735_abnormal_chemical_nociception | 1.40035560 |
| 71 | MP0005310_abnormal_salivary_gland | 1.36783148 |
| 72 | MP0002733_abnormal_thermal_nociception | 1.36602866 |
| 73 | MP0002272_abnormal_nervous_system | 1.36489013 |
| 74 | MP0003690_abnormal_glial_cell | 1.35388729 |
| 75 | MP0003787_abnormal_imprinting | 1.34518153 |
| 76 | MP0000490_abnormal_crypts_of | 1.34035215 |
| 77 | MP0000858_altered_metastatic_potential | 1.34034527 |
| 78 | MP0002638_abnormal_pupillary_reflex | 1.32956442 |
| 79 | MP0002734_abnormal_mechanical_nocicepti | 1.32282417 |
| 80 | MP0000759_abnormal_skeletal_muscle | 1.32050248 |
| 81 | MP0002572_abnormal_emotion/affect_behav | 1.31912954 |
| 82 | MP0010307_abnormal_tumor_latency | 1.31862884 |
| 83 | MP0002998_abnormal_bone_remodeling | 1.30958818 |
| 84 | MP0000747_muscle_weakness | 1.30681606 |
| 85 | MP0005369_muscle_phenotype | 1.29774340 |
| 86 | MP0001873_stomach_inflammation | 1.29163644 |
| 87 | MP0005257_abnormal_intraocular_pressure | 1.25257293 |
| 88 | MP0003763_abnormal_thymus_physiology | 1.24199751 |
| 89 | MP0001986_abnormal_taste_sensitivity | 1.21758572 |
| 90 | MP0003329_amyloid_beta_deposits | 1.19087318 |
| 91 | MP0001502_abnormal_circadian_rhythm | 1.18600357 |
| 92 | MP0001486_abnormal_startle_reflex | 1.18065143 |
| 93 | MP0009046_muscle_twitch | 1.17166132 |
| 94 | MP0004142_abnormal_muscle_tone | 1.16632420 |
| 95 | MP0005620_abnormal_muscle_contractility | 1.16339364 |
| 96 | MP0003183_abnormal_peptide_metabolism | 1.16162027 |
| 97 | MP0005535_abnormal_body_temperature | 1.15582454 |
| 98 | MP0006276_abnormal_autonomic_nervous | 1.13746284 |
| 99 | MP0003880_abnormal_central_pattern | 1.13197225 |
| 100 | MP0005451_abnormal_body_composition | 1.12396028 |
| 101 | MP0008569_lethality_at_weaning | 1.10872672 |
| 102 | MP0003633_abnormal_nervous_system | 1.09506270 |
| 103 | MP0001851_eye_inflammation | 1.08629393 |
| 104 | MP0003191_abnormal_cellular_cholesterol | 1.07356187 |
| 105 | MP0002933_joint_inflammation | 1.07318215 |
| 106 | MP0000371_diluted_coat_color | 1.06958992 |
| 107 | MP0003045_fibrosis | 1.06652061 |
| 108 | MP0001968_abnormal_touch/_nociception | 1.06044841 |
| 109 | MP0002971_abnormal_brown_adipose | 1.05580940 |
| 110 | MP0002067_abnormal_sensory_capabilities | 1.03973189 |
| 111 | MP0000750_abnormal_muscle_regeneration | 1.03804111 |
| 112 | MP0004043_abnormal_pH_regulation | 1.02642616 |
| 113 | MP0003075_altered_response_to | 1.01433205 |
| 114 | MP0001440_abnormal_grooming_behavior | 1.00938517 |
| 115 | MP0002254_reproductive_system_inflammat | 0.99975609 |
| 116 | MP0004087_abnormal_muscle_fiber | 0.98935128 |
| 117 | MP0005390_skeleton_phenotype | 0.97464772 |
| 118 | MP0003566_abnormal_cell_adhesion | 0.96668485 |
| 119 | MP0002653_abnormal_ependyma_morphology | 0.96016562 |
| 120 | MP0008260_abnormal_autophagy | 0.95484126 |
| 121 | MP0009840_abnormal_foam_cell | 0.94986663 |
| 122 | MP0000703_abnormal_thymus_morphology | 0.93937330 |
| 123 | MP0008438_abnormal_cutaneous_collagen | 0.93854225 |
| 124 | MP0001984_abnormal_olfaction | 0.93807350 |
| 125 | MP0002909_abnormal_adrenal_gland | 0.93669590 |
| 126 | MP0003646_muscle_fatigue | 0.92511749 |
| 127 | MP0000767_abnormal_smooth_muscle | 0.90549408 |
| 128 | MP0003300_gastrointestinal_ulcer | 0.90389793 |
| 129 | MP0003091_abnormal_cell_migration | 0.89981997 |
| 130 | MP0005075_abnormal_melanosome_morpholog | 0.89732447 |
| 131 | MP0004924_abnormal_behavior | 0.88434804 |
| 132 | MP0005386_behavior/neurological_phenoty | 0.88434804 |
| 133 | MP0000013_abnormal_adipose_tissue | 0.88019561 |
| 134 | MP0002557_abnormal_social/conspecific_i | 0.87411586 |
| 135 | MP0000465_gastrointestinal_hemorrhage | 0.87318585 |
| 136 | MP0004885_abnormal_endolymph | 0.86679322 |
| 137 | MP0002693_abnormal_pancreas_physiology | 0.86577118 |
| 138 | MP0001348_abnormal_lacrimal_gland | 0.85926240 |
| 139 | MP0005646_abnormal_pituitary_gland | 0.85066543 |
| 140 | MP0002078_abnormal_glucose_homeostasis | 0.84697617 |
| 141 | MP0004782_abnormal_surfactant_physiolog | 0.84253517 |
| 142 | MP0001958_emphysema | 0.83781184 |
| 143 | MP0009763_increased_sensitivity_to | 0.82220557 |
| 144 | MP0008007_abnormal_cellular_replicative | 0.81779421 |
| 145 | MP0000230_abnormal_systemic_arterial | 0.80905724 |
| 146 | MP0008874_decreased_physiological_sensi | 0.80620649 |
| 147 | MP0005448_abnormal_energy_balance | 0.80114703 |
| 148 | MP0001905_abnormal_dopamine_level | 0.78402055 |
| 149 | MP0005076_abnormal_cell_differentiation | 0.77868499 |
| 150 | MP0003828_pulmonary_edema | 0.77672660 |
| 151 | MP0005166_decreased_susceptibility_to | 0.75432980 |
| 152 | MP0000249_abnormal_blood_vessel | 0.74045866 |
| 153 | MP0002019_abnormal_tumor_incidence | 0.71119854 |
| 154 | MP0003795_abnormal_bone_structure | 0.69241031 |
| 155 | MP0002095_abnormal_skin_pigmentation | 0.68754246 |
| 156 | MP0005023_abnormal_wound_healing | 0.68176958 |
| 157 | MP0002277_abnormal_respiratory_mucosa | 0.67946670 |
| 158 | MP0003866_abnormal_defecation | 0.67573632 |
| 159 | MP0005164_abnormal_response_to | 0.64850620 |
| 160 | MP0005621_abnormal_cell_physiology | 0.60010059 |
| 161 | MP0000604_amyloidosis | 0.58875760 |
| 162 | MP0002138_abnormal_hepatobiliary_system | 0.56172602 |
| 163 | MP0001915_intracranial_hemorrhage | 0.55925128 |
| 164 | MP0003453_abnormal_keratinocyte_physiol | 0.54457124 |
| 165 | MP0010352_gastrointestinal_tract_polyps | 0.54006775 |
| 166 | MP0003279_aneurysm | 0.53061278 |
| 167 | MP0005167_abnormal_blood-brain_barrier | 0.52644408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.48528515 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 6.04959496 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.04703930 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.73187115 |
| 5 | Nemaline bodies (HP:0003798) | 5.70930139 |
| 6 | Exercise-induced myalgia (HP:0003738) | 5.52492344 |
| 7 | Eczematoid dermatitis (HP:0000976) | 5.07447728 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.98588829 |
| 9 | Myositis (HP:0100614) | 4.94892189 |
| 10 | Type 1 muscle fiber predominance (HP:0003803) | 4.75351789 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 4.40957987 |
| 12 | Orchitis (HP:0100796) | 4.33519343 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.27344998 |
| 14 | Optic neuritis (HP:0100653) | 4.14191260 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 4.14191260 |
| 16 | Recurrent skin infections (HP:0001581) | 3.93148297 |
| 17 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.91231289 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.85765659 |
| 19 | Myopathic facies (HP:0002058) | 3.82469501 |
| 20 | Increased cerebral lipofuscin (HP:0011813) | 3.80507751 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.79790026 |
| 22 | Recurrent viral infections (HP:0004429) | 3.77741987 |
| 23 | Autoimmune thrombocytopenia (HP:0001973) | 3.77693280 |
| 24 | Exercise-induced muscle cramps (HP:0003710) | 3.73107868 |
| 25 | Chronic otitis media (HP:0000389) | 3.64502890 |
| 26 | Vacuolated lymphocytes (HP:0001922) | 3.54787016 |
| 27 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.47221295 |
| 28 | Muscle fiber splitting (HP:0003555) | 3.30986075 |
| 29 | Difficulty running (HP:0009046) | 3.27520477 |
| 30 | Calf muscle hypertrophy (HP:0008981) | 3.27080588 |
| 31 | Distal arthrogryposis (HP:0005684) | 3.26991094 |
| 32 | Vasculitis (HP:0002633) | 3.25786646 |
| 33 | Gingivitis (HP:0000230) | 3.25208242 |
| 34 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.23893873 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 3.23893873 |
| 36 | Abnormality of glycolipid metabolism (HP:0010969) | 3.11479712 |
| 37 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.11479712 |
| 38 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.11479712 |
| 39 | Prostate neoplasm (HP:0100787) | 3.05139859 |
| 40 | Basal ganglia calcification (HP:0002135) | 3.04292962 |
| 41 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.01638050 |
| 42 | Systemic lupus erythematosus (HP:0002725) | 3.00911277 |
| 43 | EMG: myopathic abnormalities (HP:0003458) | 3.00391449 |
| 44 | Pulmonary infiltrates (HP:0002113) | 2.99519005 |
| 45 | Genetic anticipation (HP:0003743) | 2.99191330 |
| 46 | Obstructive lung disease (HP:0006536) | 2.99103874 |
| 47 | Chronic obstructive pulmonary disease (HP:0006510) | 2.99103874 |
| 48 | Frequent falls (HP:0002359) | 2.94860547 |
| 49 | Asymmetric septal hypertrophy (HP:0001670) | 2.94824508 |
| 50 | Ulnar deviation of the wrist (HP:0003049) | 2.92818895 |
| 51 | Periodontitis (HP:0000704) | 2.86265804 |
| 52 | Round ear (HP:0100830) | 2.84105861 |
| 53 | Diplopia (HP:0000651) | 2.83737408 |
| 54 | Abnormality of binocular vision (HP:0011514) | 2.83737408 |
| 55 | Cellulitis (HP:0100658) | 2.83409523 |
| 56 | Myoglobinuria (HP:0002913) | 2.82886408 |
| 57 | Meningitis (HP:0001287) | 2.77835491 |
| 58 | Stomatitis (HP:0010280) | 2.77720122 |
| 59 | Arterial thrombosis (HP:0004420) | 2.74955418 |
| 60 | Thrombocytosis (HP:0001894) | 2.70033613 |
| 61 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.61573732 |
| 62 | Rhabdomyolysis (HP:0003201) | 2.61153721 |
| 63 | Vertebral compression fractures (HP:0002953) | 2.59651995 |
| 64 | Hyporeflexia of lower limbs (HP:0002600) | 2.56899496 |
| 65 | Colitis (HP:0002583) | 2.56089881 |
| 66 | Leukocytosis (HP:0001974) | 2.54977346 |
| 67 | Osteomyelitis (HP:0002754) | 2.52606614 |
| 68 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.50812684 |
| 69 | Subaortic stenosis (HP:0001682) | 2.50812684 |
| 70 | Axonal loss (HP:0003447) | 2.50067444 |
| 71 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.47901571 |
| 72 | Progressive cerebellar ataxia (HP:0002073) | 2.47624159 |
| 73 | Myotonia (HP:0002486) | 2.46568774 |
| 74 | Hematochezia (HP:0002573) | 2.46537877 |
| 75 | Hemoptysis (HP:0002105) | 2.42076362 |
| 76 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.41575307 |
| 77 | Abnormality of the prostate (HP:0008775) | 2.40374754 |
| 78 | Hypergammaglobulinemia (HP:0010702) | 2.39820779 |
| 79 | Panhypogammaglobulinemia (HP:0003139) | 2.38605028 |
| 80 | Obstructive sleep apnea (HP:0002870) | 2.38411116 |
| 81 | Ankle clonus (HP:0011448) | 2.38264458 |
| 82 | Keratoconjunctivitis sicca (HP:0001097) | 2.37415152 |
| 83 | Abnormality of the calf musculature (HP:0001430) | 2.37279028 |
| 84 | Increased variability in muscle fiber diameter (HP:0003557) | 2.37158220 |
| 85 | Albinism (HP:0001022) | 2.36711616 |
| 86 | Agitation (HP:0000713) | 2.34361580 |
| 87 | Hemiplegia (HP:0002301) | 2.34182794 |
| 88 | Disinhibition (HP:0000734) | 2.34150605 |
| 89 | Inflammation of the large intestine (HP:0002037) | 2.32105325 |
| 90 | Mutism (HP:0002300) | 2.32001005 |
| 91 | Loss of speech (HP:0002371) | 2.31549900 |
| 92 | Recurrent pneumonia (HP:0006532) | 2.30674649 |
| 93 | Increased IgM level (HP:0003496) | 2.28119117 |
| 94 | Premature loss of primary teeth (HP:0006323) | 2.27926779 |
| 95 | Agnosia (HP:0010524) | 2.27065255 |
| 96 | Nasal polyposis (HP:0100582) | 2.25909603 |
| 97 | Pustule (HP:0200039) | 2.25131336 |
| 98 | Rimmed vacuoles (HP:0003805) | 2.22161415 |
| 99 | Hyperventilation (HP:0002883) | 2.21945712 |
| 100 | Agammaglobulinemia (HP:0004432) | 2.21869961 |
| 101 | Gastrointestinal inflammation (HP:0004386) | 2.21790832 |
| 102 | Recurrent lower respiratory tract infections (HP:0002783) | 2.21254793 |
| 103 | Muscle stiffness (HP:0003552) | 2.21154103 |
| 104 | Febrile seizures (HP:0002373) | 2.20033823 |
| 105 | Petechiae (HP:0000967) | 2.19723675 |
| 106 | Recurrent bronchitis (HP:0002837) | 2.19196164 |
| 107 | Interstitial pulmonary disease (HP:0006530) | 2.18526019 |
| 108 | Emphysema (HP:0002097) | 2.15826731 |
| 109 | Abnormality of the nasal mucosa (HP:0000433) | 2.15765013 |
| 110 | Gingival bleeding (HP:0000225) | 2.15175973 |
| 111 | Keratoconjunctivitis (HP:0001096) | 2.14265581 |
| 112 | Dysostosis multiplex (HP:0000943) | 2.13701933 |
| 113 | Pulmonary artery stenosis (HP:0004415) | 2.13512853 |
| 114 | EMG: neuropathic changes (HP:0003445) | 2.13028643 |
| 115 | Bundle branch block (HP:0011710) | 2.12359397 |
| 116 | Polyphagia (HP:0002591) | 2.11509392 |
| 117 | Glomerulonephritis (HP:0000099) | 2.08798825 |
| 118 | Gastrointestinal infarctions (HP:0005244) | 2.07819163 |
| 119 | Tetraparesis (HP:0002273) | 2.07377045 |
| 120 | Eosinophilia (HP:0001880) | 2.07364102 |
| 121 | Peritonitis (HP:0002586) | 2.07044155 |
| 122 | Epistaxis (HP:0000421) | 2.06583804 |
| 123 | Focal seizures (HP:0007359) | 2.04433720 |
| 124 | Abnormal eating behavior (HP:0100738) | 2.03138725 |
| 125 | Fetal akinesia sequence (HP:0001989) | 2.02941939 |
| 126 | Bone pain (HP:0002653) | 2.02424860 |
| 127 | Pathologic fracture (HP:0002756) | 2.01582308 |
| 128 | Abnormality of the fingertips (HP:0001211) | 2.00031011 |
| 129 | Abnormality of T cell physiology (HP:0011840) | 2.00014570 |
| 130 | Porencephaly (HP:0002132) | 1.99814024 |
| 131 | Ventricular fibrillation (HP:0001663) | 1.97914789 |
| 132 | Encephalitis (HP:0002383) | 1.97607463 |
| 133 | Chest pain (HP:0100749) | 1.97326141 |
| 134 | Hemiparesis (HP:0001269) | 1.96859021 |
| 135 | Focal motor seizures (HP:0011153) | 1.96827837 |
| 136 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.96481281 |
| 137 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.96481281 |
| 138 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.96481281 |
| 139 | Neck muscle weakness (HP:0000467) | 1.96374365 |
| 140 | Abnormality of the pleura (HP:0002103) | 1.92033336 |
| 141 | Bruising susceptibility (HP:0000978) | 1.91078855 |
| 142 | Spontaneous hematomas (HP:0007420) | 1.90900355 |
| 143 | Absent frontal sinuses (HP:0002688) | 1.89974405 |
| 144 | Increased IgE level (HP:0003212) | 1.89494410 |
| 145 | Thyroiditis (HP:0100646) | 1.87893868 |
| 146 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.86629206 |
| 147 | Visual hallucinations (HP:0002367) | 1.86401911 |
| 148 | Prolonged bleeding time (HP:0003010) | 1.86338675 |
| 149 | Hyperkalemia (HP:0002153) | 1.86272930 |
| 150 | Clumsiness (HP:0002312) | 1.85905971 |
| 151 | Poor head control (HP:0002421) | 1.85448071 |
| 152 | Abnormal EKG (HP:0003115) | 1.85225432 |
| 153 | Prolonged QT interval (HP:0001657) | 1.85204958 |
| 154 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.84969536 |
| 155 | Spondylolisthesis (HP:0003302) | 1.84859843 |
| 156 | Granulocytopenia (HP:0001913) | 1.84446287 |
| 157 | Postural instability (HP:0002172) | 1.81206798 |
| 158 | Oligomenorrhea (HP:0000876) | 1.80558607 |
| 159 | Bulbar palsy (HP:0001283) | 1.79957155 |
| 160 | Absence seizures (HP:0002121) | 1.75231196 |
| 161 | Broad-based gait (HP:0002136) | 1.70043989 |
| 162 | Increased connective tissue (HP:0009025) | 1.69534624 |
| 163 | Absent phalangeal crease (HP:0006109) | 1.68906120 |
| 164 | Malignant hyperthermia (HP:0002047) | 1.68415859 |
| 165 | Congenital sensorineural hearing impairment (HP:0008527) | 1.66573631 |
| 166 | Rapidly progressive (HP:0003678) | 1.65958987 |
| 167 | Ketoacidosis (HP:0001993) | 1.65081687 |
| 168 | Papilledema (HP:0001085) | 1.64707542 |
| 169 | Slender build (HP:0001533) | 1.64405474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KIT | 3.85490371 |
| 2 | MAP3K14 | 3.82331177 |
| 3 | TYK2 | 3.66494858 |
| 4 | OBSCN | 3.61127046 |
| 5 | TBK1 | 3.55509521 |
| 6 | IRAK4 | 3.48697479 |
| 7 | IRAK3 | 3.36177634 |
| 8 | IKBKE | 3.14397605 |
| 9 | PHKG2 | 2.87963537 |
| 10 | PHKG1 | 2.87963537 |
| 11 | RIPK4 | 2.87815654 |
| 12 | JAK3 | 2.69608103 |
| 13 | MAP3K13 | 2.56944967 |
| 14 | IKBKB | 2.56120036 |
| 15 | MAP4K1 | 2.55569119 |
| 16 | BLK | 2.16599628 |
| 17 | PINK1 | 2.13443718 |
| 18 | MARK1 | 2.07578913 |
| 19 | PIM2 | 2.07201976 |
| 20 | JAK1 | 2.05182126 |
| 21 | TAOK3 | 2.03533448 |
| 22 | FRK | 2.03016347 |
| 23 | CSF1R | 1.98822321 |
| 24 | TNK2 | 1.98019120 |
| 25 | ERN1 | 1.85481460 |
| 26 | DAPK2 | 1.81926351 |
| 27 | CHUK | 1.70601767 |
| 28 | MAPK12 | 1.69926532 |
| 29 | FLT3 | 1.69757035 |
| 30 | TEC | 1.62016627 |
| 31 | TXK | 1.58147122 |
| 32 | RPS6KA4 | 1.57245152 |
| 33 | MAP3K7 | 1.57215455 |
| 34 | BTK | 1.38707054 |
| 35 | CAMKK1 | 1.37643325 |
| 36 | PRPF4B | 1.36494892 |
| 37 | MARK2 | 1.35267834 |
| 38 | SYK | 1.35219559 |
| 39 | TGFBR2 | 1.31573985 |
| 40 | ZAP70 | 1.31370268 |
| 41 | PIM1 | 1.30386097 |
| 42 | MAP2K3 | 1.29573416 |
| 43 | NEK9 | 1.28018974 |
| 44 | NTRK3 | 1.27666260 |
| 45 | NTRK2 | 1.26876265 |
| 46 | CASK | 1.26537660 |
| 47 | MAPK13 | 1.25616454 |
| 48 | NME2 | 1.24994428 |
| 49 | FES | 1.21771129 |
| 50 | HCK | 1.19750108 |
| 51 | MAP2K4 | 1.09924179 |
| 52 | MAP2K6 | 1.08380455 |
| 53 | LCK | 1.06906706 |
| 54 | CDC42BPA | 1.06558438 |
| 55 | CSK | 1.03472766 |
| 56 | TTN | 1.01777257 |
| 57 | LYN | 0.99192841 |
| 58 | DYRK1B | 0.97692001 |
| 59 | MAPK7 | 0.96098109 |
| 60 | CAMKK2 | 0.96010971 |
| 61 | INSRR | 0.95845908 |
| 62 | MAP4K2 | 0.95344533 |
| 63 | PKN1 | 0.95092250 |
| 64 | MATK | 0.91311891 |
| 65 | PRKD2 | 0.88323211 |
| 66 | SGK2 | 0.87950616 |
| 67 | CAMK4 | 0.86837496 |
| 68 | MAP3K1 | 0.82537520 |
| 69 | CDK19 | 0.82187285 |
| 70 | BMPR2 | 0.82072754 |
| 71 | TRPM7 | 0.82063966 |
| 72 | SGK223 | 0.81543341 |
| 73 | SGK494 | 0.81543341 |
| 74 | CAMK1 | 0.81489891 |
| 75 | CLK1 | 0.81143763 |
| 76 | MOS | 0.79147297 |
| 77 | RIPK1 | 0.78607890 |
| 78 | MAP3K6 | 0.77114458 |
| 79 | JAK2 | 0.76450174 |
| 80 | TYRO3 | 0.76399965 |
| 81 | SIK2 | 0.74656003 |
| 82 | YES1 | 0.74111852 |
| 83 | EIF2AK2 | 0.72825039 |
| 84 | PRKCH | 0.72391771 |
| 85 | MAP3K4 | 0.70695069 |
| 86 | SIK1 | 0.67964920 |
| 87 | PDK1 | 0.66908927 |
| 88 | STK11 | 0.66837177 |
| 89 | MAP3K5 | 0.66739968 |
| 90 | ARAF | 0.66069988 |
| 91 | SIK3 | 0.65853397 |
| 92 | BCKDK | 0.64559016 |
| 93 | SGK3 | 0.64538605 |
| 94 | MARK3 | 0.64199277 |
| 95 | STK4 | 0.63892300 |
| 96 | STK10 | 0.63558752 |
| 97 | EPHB1 | 0.61916885 |
| 98 | ABL1 | 0.61335522 |
| 99 | RPS6KA6 | 0.60163488 |
| 100 | CAMK1D | 0.59846362 |
| 101 | PAK6 | 0.59763074 |
| 102 | MAPK15 | 0.59636638 |
| 103 | PRKAA1 | 0.58726254 |
| 104 | TAOK2 | 0.57538692 |
| 105 | PRKCQ | 0.56801457 |
| 106 | MAP3K11 | 0.56749986 |
| 107 | CDK5 | 0.56145729 |
| 108 | UHMK1 | 0.56040223 |
| 109 | PRKAA2 | 0.55171443 |
| 110 | FGR | 0.55116304 |
| 111 | ABL2 | 0.54878718 |
| 112 | PIK3CG | 0.54834812 |
| 113 | NLK | 0.54782423 |
| 114 | MAPK4 | 0.53488198 |
| 115 | BMX | 0.53123127 |
| 116 | PRKCZ | 0.52872243 |
| 117 | PDPK1 | 0.52215057 |
| 118 | GRK7 | 0.50709703 |
| 119 | FGFR2 | 0.50109126 |
| 120 | STK3 | 0.49785441 |
| 121 | EPHA3 | 0.49458901 |
| 122 | PTK6 | 0.47392147 |
| 123 | EEF2K | 0.46816518 |
| 124 | PBK | 0.45223677 |
| 125 | MUSK | 0.44247899 |
| 126 | NUAK1 | 0.44104185 |
| 127 | TAOK1 | 0.43904799 |
| 128 | TRIB3 | 0.40081329 |
| 129 | MAP3K10 | 0.39866961 |
| 130 | MAPKAPK2 | 0.39674688 |
| 131 | EGFR | 0.39059071 |
| 132 | ITK | 0.38735497 |
| 133 | FGFR4 | 0.38326152 |
| 134 | IRAK1 | 0.37323993 |
| 135 | MAP3K3 | 0.36804967 |
| 136 | CDK12 | 0.36725084 |
| 137 | ATR | 0.36584804 |
| 138 | PAK4 | 0.36163810 |
| 139 | RPS6KC1 | 0.35820397 |
| 140 | RPS6KL1 | 0.35820397 |
| 141 | PRKCD | 0.35740212 |
| 142 | FGFR3 | 0.34311181 |
| 143 | MAPKAPK3 | 0.34276995 |
| 144 | TGFBR1 | 0.34021921 |
| 145 | PKN2 | 0.33781041 |
| 146 | PLK4 | 0.33337198 |
| 147 | NEK2 | 0.33323510 |
| 148 | HIPK2 | 0.30170005 |
| 149 | PRKG2 | 0.30033356 |
| 150 | ADRBK2 | 0.29619156 |
| 151 | IRAK2 | 0.29591246 |
| 152 | RPS6KA2 | 0.29011836 |
| 153 | CDK6 | 0.27870881 |
| 154 | LRRK2 | 0.27565498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.07277116 |
| 2 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.75408539 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.68111511 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.67114073 |
| 5 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.43946309 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.36724256 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.36478453 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.19087447 |
| 9 | Influenza A_Homo sapiens_hsa05164 | 2.07356065 |
| 10 | Malaria_Homo sapiens_hsa05144 | 2.05584602 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.03372509 |
| 12 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.01147695 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.95077366 |
| 14 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.92144843 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.90822763 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 1.88235666 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.86416653 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.84677252 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.83413032 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.78367440 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.77516634 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.75010030 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.70676926 |
| 24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.68252347 |
| 25 | Apoptosis_Homo sapiens_hsa04210 | 1.61387052 |
| 26 | Insulin secretion_Homo sapiens_hsa04911 | 1.60486662 |
| 27 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.59654234 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.54536212 |
| 29 | Circadian entrainment_Homo sapiens_hsa04713 | 1.51691573 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.50367021 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.49997148 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49272551 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46772600 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.45561304 |
| 35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.44704090 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.42621004 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.38514607 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.35620464 |
| 39 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.34328684 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.34087175 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.32727563 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.31993058 |
| 43 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.28423818 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.27777432 |
| 45 | Morphine addiction_Homo sapiens_hsa05032 | 1.27755030 |
| 46 | Nicotine addiction_Homo sapiens_hsa05033 | 1.26122398 |
| 47 | Renin secretion_Homo sapiens_hsa04924 | 1.25585787 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.24835032 |
| 49 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.24041980 |
| 50 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.23724619 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.23600580 |
| 52 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.23540961 |
| 53 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23334682 |
| 54 | Asthma_Homo sapiens_hsa05310 | 1.23181336 |
| 55 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.21958542 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.21217215 |
| 57 | GABAergic synapse_Homo sapiens_hsa04727 | 1.15865759 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 1.15710683 |
| 59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15594539 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 1.15471095 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.15361670 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.09167721 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.09143047 |
| 64 | Long-term depression_Homo sapiens_hsa04730 | 1.08483267 |
| 65 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08128505 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.07543062 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07491228 |
| 68 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.06684895 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.06536851 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.05281389 |
| 71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.04814723 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04191428 |
| 73 | Salivary secretion_Homo sapiens_hsa04970 | 1.03537136 |
| 74 | Long-term potentiation_Homo sapiens_hsa04720 | 1.01678643 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.01425654 |
| 76 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98790928 |
| 77 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98681042 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.96795431 |
| 79 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.96263468 |
| 80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91725887 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.90662160 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.89956537 |
| 83 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.89787739 |
| 84 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.89093979 |
| 85 | Base excision repair_Homo sapiens_hsa03410 | 0.88437520 |
| 86 | Cocaine addiction_Homo sapiens_hsa05030 | 0.88307188 |
| 87 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.88093621 |
| 88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.87832405 |
| 89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.87298656 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86773325 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86454230 |
| 92 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.86445658 |
| 93 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.83882125 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.83286469 |
| 95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82604013 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82018996 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79776281 |
| 98 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.78600444 |
| 99 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.78134579 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76697686 |
| 101 | Amoebiasis_Homo sapiens_hsa05146 | 0.76555890 |
| 102 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.76433838 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.76299580 |
| 104 | Platelet activation_Homo sapiens_hsa04611 | 0.74640954 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74050703 |
| 106 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.73790185 |
| 107 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73007624 |
| 108 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71676935 |
| 109 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70922867 |
| 110 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.69648148 |
| 111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.68129798 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.67866910 |
| 113 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.66103865 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65600206 |
| 115 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65472253 |
| 116 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.65009003 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64896196 |
| 118 | Homologous recombination_Homo sapiens_hsa03440 | 0.64478195 |
| 119 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.63030534 |
| 120 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60598241 |
| 121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60140362 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59249559 |
| 123 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59248359 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59224241 |
| 125 | DNA replication_Homo sapiens_hsa03030 | 0.57513777 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56864370 |
| 127 | Taste transduction_Homo sapiens_hsa04742 | 0.56686686 |
| 128 | ABC transporters_Homo sapiens_hsa02010 | 0.56635054 |
| 129 | Phototransduction_Homo sapiens_hsa04744 | 0.56010970 |
| 130 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48905728 |
| 131 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44207667 |
| 132 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42298455 |
| 133 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38281071 |
| 134 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38046808 |
| 135 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36565771 |
| 136 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.36265427 |
| 137 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35987454 |
| 138 | Colorectal cancer_Homo sapiens_hsa05210 | 0.35489556 |
| 139 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34525916 |
| 140 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33103157 |
| 141 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31335652 |
| 142 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28841888 |
| 143 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28634800 |
| 144 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26036733 |
| 145 | Insulin resistance_Homo sapiens_hsa04931 | 0.25736673 |
| 146 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25709991 |
| 147 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.25629993 |
| 148 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24798872 |
| 149 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.23970673 |
| 150 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.21784510 |
| 151 | Mismatch repair_Homo sapiens_hsa03430 | 0.20978263 |
| 152 | Cell cycle_Homo sapiens_hsa04110 | 0.20249014 |

